Dohan O - Search Results

1

The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.

Wapnir IL, Goris M, Yudd A, Dohan O, Adelman D, Nowels K, Carrasco N. Wapnir IL, et al. Among authors: dohan o. Clin Cancer Res. 2004 Jul 1;10(13):4294-302. doi: 10.1158/1078-0432.CCR-04-0074. Clin Cancer Res. 2004. PMID: 15240514

2

Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections.

Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohán O, Carrasco N. Wapnir IL, et al. Among authors: dohan o. J Clin Endocrinol Metab. 2003 Apr;88(4):1880-8. doi: 10.1210/jc.2002-021544. J Clin Endocrinol Metab. 2003. PMID: 12679487

3

Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.

Dohán O, Carrasco N. Dohán O, et al. Mol Cell Endocrinol. 2003 Dec 31;213(1):59-70. doi: 10.1016/j.mce.2003.10.059. Mol Cell Endocrinol. 2003. PMID: 15062574 Review.

4

Thyroidal iodide transport and thyroid cancer.

Dohán O, Carrasco N. Dohán O, et al. Cancer Treat Res. 2004;122:221-36. doi: 10.1007/1-4020-8107-3_13. Cancer Treat Res. 2004. PMID: 16209048 Review. No abstract available.

5

Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells.

Dohán O, De la Vieja A, Carrasco N. Dohán O, et al. Mol Endocrinol. 2006 May;20(5):1121-37. doi: 10.1210/me.2005-0376. Epub 2006 Jan 26. Mol Endocrinol. 2006. PMID: 16439463 Free article.

6

Expression of the Na+/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus.

Altorjay A, Dohán O, Szilágyi A, Paroder M, Wapnir IL, Carrasco N. Altorjay A, et al. Among authors: dohan o. BMC Cancer. 2007 Jan 10;7:5. doi: 10.1186/1471-2407-7-5. BMC Cancer. 2007. PMID: 17214887 Free PMC article.

7

The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.

Dohán O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. Dohán O, et al. Endocr Rev. 2003 Feb;24(1):48-77. doi: 10.1210/er.2001-0029. Endocr Rev. 2003. PMID: 12588808 Review.

8

Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.

Zuckier LS, Dohan O, Li Y, Chang CJ, Carrasco N, Dadachova E. Zuckier LS, et al. Among authors: dohan o. J Nucl Med. 2004 Mar;45(3):500-7. J Nucl Med. 2004. PMID: 15001694 Free article.

9

Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology.

Dohan O, De la Vieja A, Carrasco N. Dohan O, et al. Trends Endocrinol Metab. 2000 Apr;11(3):99-105. doi: 10.1016/s1043-2760(00)00237-x. Trends Endocrinol Metab. 2000. PMID: 10707050

10

Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.

De La Vieja A, Dohan O, Levy O, Carrasco N. De La Vieja A, et al. Among authors: dohan o. Physiol Rev. 2000 Jul;80(3):1083-105. doi: 10.1152/physrev.2000.80.3.1083. Physiol Rev. 2000. PMID: 10893432 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters